Table 1 Patient characteristics
Naloxone(n = 35) | Non-naloxone (n = 34) | P Value | |
|---|---|---|---|
Age(y) | 55.46 ± 8.65 | 55.46 ± 8.65 | 0.378 |
Gender, N(%) | 0.900 | ||
Male | 17(48.57) | 16(47.06) | |
Female | 18(51.43) | 18(52.94) | |
Body mass index (kg/m2) | 25.42 ± 4.19 | 24.52 ± 3.67 | 0.351 |
ASA physical status, N (%) | 1.000 | ||
II | 31(88.57) | 30(11.76) | |
III | 4(11.43) | 4(88.24) | |
Type of operation, N (%) | 0.777 | ||
Video-assisted thoracoscopic pulmonary lobectomy | 25(71.43) | 26(76.47) | |
Video-assisted thoracoscopic pulmonary wedge resection | 9(25.71) | 8(23.93) | |
Video-assisted thoracoscopic pulmonary segmentary | 1(2.86) | 0(0.00) | |
Duration of operation (min) | 150.00 (120.00–180.00) | 180.00 (120.00–180.00) | 0.339 |
Fluid intake (mL) | 1000.00(1000.00–1000.00) | 1000.00(1000.00–1000.00) | 0.854 |
Blood loss (mL) | 113.71 ± 38.278 | 106.76 ± 36.987 | 0.446 |
Type of cancer, N (%) | 0.780 | ||
Carcinoma in situ | 8(22.85) | 6(17.65) | |
Microinvasive adenocarcinoma | 14(40.00) | 11(32.35) | |
infiltrating adenocarcinoma | 12(34.29) | 14(41.18) | |
Mucinous adenocarcinoma | 1(2.86) | 2(5.88) | |
Moderately differentiated adenocarcinoma | 0(0.00) | 1(2.94) | |
Lymphatic metastasis | 0.614 | ||
Yes | 1(2.86) | 2(5.88) | |
No | 34(97.14) | 32(94.12) |